Correlation Between DiaMedica Therapeutics and XORTX Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and XORTX Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and XORTX Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and XORTX Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and XORTX is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and XORTX Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and XORTX Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.41 times more return on investment than XORTX Therapeutics. However, DiaMedica Therapeutics is 2.45 times less risky than XORTX Therapeutics. It trades about 0.08 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 144.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 422.00 from holding DiaMedica Therapeutics or generate 293.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. XORTX Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| XORTX Therapeutics |
DiaMedica Therapeutics and XORTX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and XORTX Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| XORTX Therapeutics vs. DiaMedica Therapeutics | XORTX Therapeutics vs. Lyra Therapeutics | XORTX Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |